NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised people

A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have declined, while additional dose is given to immunocompromised and immunosuppressed individuals when primary schedule of vaccination does not provide adequate protection from the infection and disease, they explained.
Source: The Economic Times - Category: Consumer Health News Source Type: news

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
HELSINKI — Thousands of people gathered in European capitals Saturday to protest vaccine passports and other requirements governments have imposed in hopes of ending the coronavirus pandemic. #helsinki #passportprotests #capitals #requirementsgovernments
Source: Reuters: Health - Category: Consumer Health News Source Type: news
[Africa Renewal] Clad in a torn and tattered orange overall, 25-year-old Brandon Ndlovu cuts a lone figure at Benoni, in Johannesburg, one of South Africa's busiest shopping centres. He does not feel part of the shoppers on the streets because he has not been vaccinated against COVID-19.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Can Fam Physician. 2022 Jan;68(1):17-18. doi: 10.46747/cfp.680117.ABSTRACTQUESTION: With the approval of coronavirus disease 2019 (COVID-19) vaccine for children 5 to 11 years of age and concerns among parents in the past year following reported cases of myocarditis and pericarditis in adolescents, should my office continue to encourage all children and young adults to receive the COVID-19 messenger RNA vaccine?ANSWER: Since April 2021 reports have documented cases of myocarditis and pericarditis in adolescents and young adults after messenger RNA COVID-19 vaccination, and several hundred such reports were documented in Ca...
Source: Canadian Family Physician Medecin de Famille Canadien - Category: Primary Care Authors: Source Type: research
PATIENTS in dire need of coronavirus protection may not be receiving the full benefits of the vaccine, a study has warned.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
COVID-19 vaccines work incredibly well at preventing severe disease, but future boosters will likely need to be tailored to target new and existing variants, strengthen immunity and ultimately help regain control over the pandemic. 
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
Within hours of the singer Meat Loaf's death on Thursday after a reported bout with COVID-19, some took to social media to mock his stances opposing mask and vaccine mandates. #meatloaf #bout
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Source: Journal of Neurology - Category: Neurology Source Type: research
Extra vaccine doses were expected to lower infection rates. But the shots also seem to be preventing severe illness caused by the new variant, the C.D.C. reported.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Coronavirus Omicron Variant Coronavirus Delta Variant Disease Rates Centers for Disease Control and Prevention United States Source Type: news
AbstractPurpose of ReviewWhile solid organ transplant (SOT) recipients are at the highest risk for severe complications and increased mortality from COVID19 disease, their vaccination against SARS-CoV-2 remains challenging due to fear of immune-mediated adverse events and suboptimal immune response. Our current review is aimed to summarize current knowledge about the safety and efficacy of SARS-CoV-2 vaccines, describe factors that are correlated with immune response, and discuss strategies to improve vaccine immunogenicity in SOT recipients.Recent FindingsSARS-CoV-2 vaccines are safe in SOT recipients and not related to r...
Source: Current Transplantation Reports - Category: Transplant Surgery Source Type: research
More News: COVID-19 | Health | Vaccines